Keyphrases
Activating Transcription Factor 3 (ATF3)
70%
Advanced Prostate Cancer
10%
Androgen Receptor
10%
Anti-prostate Cancer
10%
Anticancer Agents
10%
Anticancer Drugs
10%
Anticipated Outcomes
10%
Bortezomib
50%
Cancer Causes
10%
Cancer Cells
20%
Cancer Mortality
10%
Cancer Patients
10%
Cancer Strategy
10%
Cell Death
10%
Clinical Trials
10%
Clinically Significant
20%
Deprivation
10%
Drug Therapeutics
10%
Enzalutamide
10%
FDA-approved Drugs
20%
Ferroptosis
100%
Further Development
10%
Good Safety
10%
Hormone Deprivation Therapy
10%
Hormone Production
10%
Hormone Receptor
10%
Hormone Therapy
20%
Improved Outcomes
10%
Inducing Agents
10%
Lymphoma
10%
Male Hormones
30%
Mouse Model
30%
Myeloma
10%
New Therapeutic Strategies
10%
Patients with Cancer
10%
Prostate Cancer
100%
Prostate Cancer Cells
60%
Prostate Cancer Patients
10%
Prostate Radiotherapy
10%
Resistant Prostate Cancer
20%
Resume
10%
Safety Profile
10%
Selling
10%
Skin Cancer
10%
Therapeutic Strategies
10%
Therapy Treatment
10%
Therapy-resistant
10%
Treatment Options
10%
Trial Results
10%
Velcade
30%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
9%
Bortezomib
38%
Disease
9%
Endocrine Therapy
9%
Ferroptosis
100%
Malignant Neoplasm
14%
Mouse Model
14%
Prostate Cancer
100%